Market revenue in 2023 | USD 18.2 million |
Market revenue in 2030 | USD 44.7 million |
Growth rate | 13.7% (CAGR from 2023 to 2030) |
Largest segment | Web & cloud based |
Fastest growing segment | Web & Cloud based |
Historical data | 2017 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Web & Cloud based, On premise |
Key market players worldwide | IQVIA Holdings Inc, Medidata, Oracle Corp, DATATRAK International Inc, Clario, PAREXEL, Labcorp Holdings Inc, Veeva Systems Inc Class A, Wipro Ltd ADR |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to clinical trials management system market will help companies and investors design strategic landscapes.
Web & cloud based was the largest segment with a revenue share of 70.88% in 2023. Horizon Databook has segmented the Russia clinical trials management system market based on web & cloud based, on premise covering the revenue growth of each sub-segment from 2017 to 2030.
Russia’s foothold in clinical trials has seen massive growth from 71 trials in 2017 to reach 797 trials in 2021. However, owing to the ongoing war between Russia and Ukraine, many private companies have pulled their clinical services out of Russia and many countries have imposed sanctions against the country.
Since the country is one of the top hosts for clinical trials, the sanctions might have a negative impact on drug development pipelines at the global level. In the first half of 2022, the number of new international clinical trials has sharply declined in Russia.
Although new international trials have decreased, the country was still the leader in the number of ongoing trials with 1,400 protocols, as of 2022. Therefore, the significant number of trials creates opportunities for CTMS usage, contributing to market growth.
Horizon Databook provides a detailed overview of country-level data and insights on the Russia clinical trials management system market , including forecasts for subscribers. This country databook contains high-level insights into Russia clinical trials management system market from 2017 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account